Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease: Comparison with a busulphan-cyclophosphamide regimen

Acta Oncologica

Volumn 43, Issue 2, 2004, Pages 196-203

  Lähteenmäki, Päivi M ^a,b   Chakrabarti, Suparno ^a   Cornish, Jacqueline M ^a   Oakhill, Anthony H ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRAFT REJECTION; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; ASSOCIATION; BACTERIAL INFECTION; BEHAVIOR DISORDER; BRAIN DISEASE; BRAIN TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER THERAPY; CARDIOTOXICITY; CATARACT; CENTRAL NERVOUS SYSTEM; CHILD; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL DISORDER; DIARRHEA; DISEASE SEVERITY; EVALUATION; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; GROWTH HORMONE DEFICIENCY; HEARING IMPAIRMENT; HEART FAILURE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; HYPERACTIVITY; HYPERTENSION; HYPOTHYROIDISM; INCIDENCE; INFANT; LEARNING DISORDER; LUNG TOXICITY; MALE; MUCOSA INFLAMMATION; NEUTROPHIL; PEDIATRICS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEIZURE; STEM CELL TRANSPLANTATION; THROMBOCYTE; TREATMENT OUTCOME; VIRUS INFECTION; WHOLE BODY RADIATION;

BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; MALE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 11144354955     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310023471     Document Type: Article

References (24)

1. Brochstein JA, Kernan NA, Groschen S, et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukaemia. N Engl J Med 1987; 317: 1618-24.
2. Oakhill A, Pamphilon DH, Potter MN, et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574-8.
3. Saarinen UM, Mellander L, Nysom K, et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukaemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO). Bone Marrow Transplant 1996; 17: 357-63.
4. Woolfrey AE, Anasetti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukaemia in children. Blood 2002; 99: 2002-8.
5. Michel G, Socié G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukaemia in first complete remission: the impact of conditioning regimen without total-body irradiation - a report from the Société Francaise de Greffe de Moelle. J Clin Oncol 1997; 15: 2238-46.
6. Hopewell JW. Radiation injury to the central nervous system. Med Pediatr Oncol 1998; (Suppl 1): 1-9.
7. Bleyer WA. Chemoradiotherapy interactions in the central nervous system. Med Pediatr Oncol 1998; (Suppl 1): 10-16.
8. Giorgiani G, Bozzola M, Locatelli F, et al. Role of busulphan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825-31.
9. Sanders JE. Endocrine problems in children after bone marrow transplantation for hematological malignancies. Bone Marrow Transplant 1991; 8(Suppl 1): 2-4.
10. Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Pædiatr 1995; (Suppl 411): 57-61.
11. Carlson K. Lönnerholm G, Smedmyr B, et al. Thyroid function after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10: 123-7.
12. Cohen A, Rovelli A, Bakker B, et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the working party for late effects-EBMT. Blood 1999; 93: 4109-15.
13. Holmström G, Borgström B, Calissendorff B. Cataract in children after bone marrow transplantation: relation to conditioning regimen. Acta Ophthalmol Scand 2002; 80: 211-5.
14. Ringden O, Labopin M, Tura S, et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Br J Haematol 1996; 93: 637-45.
15. Ringden O, Remberger M, Ruutu T, et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulphan versus total body irradiation: long-term results of a randomised trial in allogeneic marrow recipients with leukemia. Blood 1999; 93: 2196-201.
16. Favre C, Nardi M, Dini G, et al. The role of total body irradiation (TBI). Bone Marrow Transplant 1996; 18(Suppl 2): 71-4.
17. Davies SM, Ramsay NKC, Klein JP, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukaemia. J Clin Oncol 2000; 18: 340-7.
18. Deeg HJ, Sullivan KM, Buckner CD, et al. Marrow transplantation for acute non-lymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151-7.
19. Socie G, Devergie A, Girinsky T, et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int J Radiat Oncol Biol Phys 1991; 20: 397-404.
20. Appelbaum FR. The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation. Semin Oncol 1993; 20(Suppl 4): 3-10.
21. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
22. Socié G, Clift RA, Blaise D, et al. Busulphan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569-74.
23. Bacigalupo A, Lamparelli T, Gualandi F, et al. Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: a 10-year follow-up of a randomized study. Blood 2001; 98: 3174-5.
24. Uzunel M, Mattson J, Jaksch M, Remberger M, Ringden O. The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation patients with acute lymphoblastic leukemia. Blood 2001; 98: 1982-4.